NCT05114746 2026-03-16
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan
Novartis
Phase 2 Active not recruiting
Novartis
Novartis
Novartis
Novartis
Novartis
OncoC4, Inc.
Canadian Cancer Trials Group
Weill Medical College of Cornell University
Peter MacCallum Cancer Centre, Australia
Peter MacCallum Cancer Centre, Australia
Peter MacCallum Cancer Centre, Australia